Results 91 to 100 of about 393,880 (203)
Vaccine waning and mumps re-emergence in the USA
Background Following decades of declining mumps incidence amid widespread vaccination, the US has experienced a resurgence in mumps cases since 2006 driven largely by outbreaks on college campuses.
Joseph Lewnard, Yonatan H Grad
core +2 more sources
Resurgence of Mumps in India: A Call to Reintroduce MMR into the Immunization Program
The recent rise in mumps outbreaks across several Indian states exposes a critical gap in the national immunization framework specifically, the absence of mumps vaccination in the Universal Immunization Programme (UIP).
Lalithambigai Chellamuthu, Anlin Jenisha
doaj +1 more source
'MMR talk' and vaccination choices: an ethnographic study in Brighton [PDF]
In the context of the high-profile controversy that has unfolded in the UK around the measles, mumps and rubella (MMR) vaccine and its possible adverse effects, this paper explores how parents in Brighton, southern England, are thinking about MMR for ...
Poltorak, Mike +3 more
core
Background and objectives: Plane wart treatment is challenging; modalities such as cauterization and cryotherapy having a great probability to recur, as well as the riskĀ of scarring, discomfort, and expensive costs.
Banu Muhammed Jaza Noori +1 more
doaj +1 more source
Validation of the diagnosis of autism in general practitioner records [PDF]
Background: We report on the validity of the computerized diagnoses of autism in a large case-control study investigating the possible association between autism and the measles, mumps and rubella vaccine in the UK using the General Practitioner Research
Eric Fombonne +34 more
core +2 more sources
Long-term persistence of vaccine-induced mumps antibodies in university students, Belgium [PDF]
Background and aims: Previous Belgian recommendations for immunization included measles-mumps-rubella (MMR)-vaccine at 15 months and 10-12 years of age. In 1999, estimated MMR1-vaccination coverage at 24 months of age was 83.4%, and own research showed a
Hoppenbrouwers, Karel +4 more
core
Safety analysis of a live attenuated mumps vaccine in healthy adolescents in China: A phase 4, observational, open-label trial. [PDF]
Hu W +7 more
europepmc +1 more source
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s Cadila Healthcare Limited, India (Cadila MMR vaccine ...
Ashwani Sood +10 more
doaj +1 more source
Recognising and Addressing Vaccine Hesitancy That Is Not Always Directly Voiced by a Child's Parents
Acta Paediatrica, Volume 115, Issue 11, Page 2514-2517, November 2026.
Alessandro Diana
wiley +1 more source

